The neuroendocrinology of chronic fatigue syndrome: focus on the hypothalamic-pituitary-adrenal axis.
D003346:Corticotropin-Releasing Hormone / Q000502:physiology; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000503:physiopathology; D005081:Exercise Therapy; D015673:Fatigue Syndrome, Chronic / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy; D005260:Female; D005356:Fibromyalgia / Q000503:physiopathology; D005938:Glucocorticoids / Q000172:deficiency; D019382:Human Growth Hormone / Q000502:physiology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D008297:Male; D008954:Models, Biological; D018847:Opioid Peptides / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D012701:Serotonin / Q000378:metabolism; D013256:Steroids / Q000627:therapeutic use; D013312:Stress, Physiological / Q000503:physiopathology*; D014667:Vasopressins / Q000502:physiology